Back to BCAX

Vestal Point Capital, LP → BCAX

Vestal Point Capital, LP BCAX Position History

Bicara Therapeutics Inc. • Healthcare

Quarters held
4
Latest value
$102.8M
Q3 2026
Peak value
$155.9M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$60.2M
Q1 2026$107.9M
Q2 2026$155.9M
Q3 2026$102.8M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$102.8M5.53M——
Q2 2026$155.9M5.25M——
Q1 2026$107.9M5.42M——
Q4 2025$60.2M3.58M——

Other funds holding BCAX

Other Vestal Point Capital, LP positions

AAVXF

Abivax SA

$392.1M
NBIX

Neurocrine Biosciences Inc

$354.6M
BMRN

BioMarin Pharmaceutical Inc

$344.8M
BMRN

BioMarin Pharmaceutical Inc

$331.5M
NBIX

Neurocrine Biosciences Inc

$316.8M
ARWR

Arrowhead Pharmaceuticals Inc

$315.1M
AAVXF

Abivax SA

$313.1M
INSM

Insmed Inc

$311M